CPHI Annual Report 2023 “AI Transforming Manufacturing, the Rise of India, and the Return of Capital and the Contract Services Boom” features an article and commentary by Bikash Chatterjee.
PART 1: Artificial Intelligence, Machine Learning and the Future of PAT 21 – pp-22-28
How Will Artificial Intelligence Impact Drug Development and Pharmaceutical Manufacturing?
Bikash Chatterjee, President and Chief Science Officer, Pharmatech Associates- a USP Company
Will AI be more beneficial in cell or gene therapies, and what are the reasons for this?
“AI has the capacity to impact both, in myriad ways. There is a huge potential for gene therapy because AI’s ability to predict protein structures has been shown to enhance the DNA scissor technology like CRISPR, by making more cuts in a patient’s DNA more precise.”
Bikash Chatterjee, President & Chief Science Officer, Pharmatech Associates.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
22320 Foothill Blvd. Suite 330, Hayward CA 94541